Please login to the form below
11
Revenue 2017AstraZeneca
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.
AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement
AstraZeneca has signed a new licencing agreement with UK-based biotechnology company, RQ BIO, for its portfolio of early-stage monoclonal antibodies targeting SARS-CoV-2. ... global player in AstraZeneca.
NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
AstraZeneca (AZ) has announced that the National Institute for Health and Care Excellence (NICE) has approved the routine use of Imfinzi (durvalumab) within NHS England as a monotherapy to treat locally
Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
AstraZeneca (AZ) and Avillion have announced positive phase 3 trial results from the MANDALA study, showing that PT027 – albuterol/budesonide – demonstrated a statistically significant decrease in the risk of a severe ... Mene Pangalos, executive
Targacept picks Solvay's Stephen Hill to fill vacant CEO post
The company then suffered another major blow earlier this year when poor late-stage trial results for an antidepressant candidate abruptly brought about the end of its collaboration with AstraZeneca.
AstraZeneca’s Imfinzi plus chemotherapy accepted for Priority Review in the US
AstraZeneca’s (AZ) has announced that its treatment, Imfinzi (durvalumab), in combination with chemotherapy, has been accepted and given a Priority Review in the US for patients with locally advanced or
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Head of Health Psychology, London
-
Highly competitive salary
- Scientists discover new approach to treat brain tumours
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- BMA appoints two internal candidates to share the role of chief executive officer
- Taking a holistic approach to patient care
- Almirall and Evotec team up in multi-target dermatology alliance
- AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement
- Innovative Medical Solutions for Postponing and Undoing Age-Related Disease
- Almirall and Evotec team up in multi-target dermatology alliance
- Moderna wins Prix Galien UK Award for best biotechnology product
- Why testing shouldn't be confined to the lab
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Live Webinar: Engaging Patients "Just-In-Time" with Machine Learning
- BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
- Celebrating the power of knowledge on International Thalassaemia Day 2022
- Rare Disease Day – looking to the future with hope
- BMA appoints two internal candidates to share the role of chief executive officer
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Eli Lilly and Incyte's Olumiant approved by FDA for hospitalised COVID-19 patients
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
- Serious about sustainability?
- Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
